ArticleBMC health services research2025
Feasibility, utility, usability and acceptance of a multimodal telemonitoring for COVID-19 patients in general practitioners practices in Germany: a mixed methods study with patients.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring the COVID-19 pandemic, infected outpatients were at risk of declining at home without themselves and their general practitioner (GP) noticing, above all due to silent hypoxemia. To support patients in quarantine, telemonitoring solutions were developed for primary care in several countries. However, evidence on patient perceptions of COVID-19 telemonitoring in primary care settings remains limited. This prospective study evaluates COVID-19 outpatients' experiences with and perception of the usability, utility and acceptance of an app-based telemonitoring in Germany, identifying key conditions for its successful implementation.
methodsTo support home-isolated COVID-19 patients remotely, eight GP practices in Germany implemented a multimodal telemonitoring system. Telemonitoring consisted of an app with connected sensors to remotely measure vital signs and symptoms, with data transmitted to a GP telemedicine platform. Between January to December 2021, 34 COVID-19 outpatients participated in telemonitoring. Telemonitoring duration was 28 days for acute infection or up to 12 weeks for prolonged/post-acute symptoms. Afterwards, patients participated in a mixed-methods evaluation about their experiences consisting of semi-structured telephone interviews and an in-house questionnaire. Interviews were analyzed using qualitative content analysis, questionnaires were analyzed descriptively.
resultsAll patients (34/34) completed the study (female = 22/34, 65%; median
conclusionsThis study demonstrates that app-based telemonitoring in primary care is a feasible, well-accepted intervention for COVID-19 outpatients, with patients perceiving it as valuable, supportive and reassuring. Findings emphasize the critical role of patient-centered design and strong support structures for successful telemonitoring integration into primary care. Lastly, these findings underscore the value of telemonitoring in pandemic preparedness, ensuring timely detection of patient deterioration and strengthening primary care resilience.
trial registrationThe study was registered with the German Clinical Trials Register (DRKS00024604). The study was approved by the Ethics Committee of Goethe University Frankfurt (No. 20-1023, 18.01.2021), and written informed consent was obtained from all participants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.